Caribbean

Resilience System


You are here

Home

Global

Pfizer ends vaccine trial with 95% success rate, paving way for a shot this year

Wed, 2020-11-18 08:49 — mike kraft
Pfizer ends vaccine trial with 95% success rate, paving way for a shot this year Final results from Pfizer Inc's COVID-19 vaccine trial showed its shot had a 95% success rate and two months of safety data, paving the way for the drugmaker to apply for an emergency U.S. authorization within days, it said on Wednesday. Michael Erman U.S.
Country / Region Tags: 
Germany
Global
United States
General Topic Tags: 
COVID-19
Contagion
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Covid testing before flying could become the norm as airlines try to boost confidence and woo travelers

Tue, 2020-11-17 11:56 — mike kraft
Covid testing before flying could become the norm as airlines try to boost confidence and woo travelers More than 100 countries already require proof of a negative coronavirus test for entry. Lori Aratani, Ian Duncan Washington Post
Country / Region Tags: 
Europe
Global
United Nations
United States
General Topic Tags: 
COVID-19
Disease
Economics
Health
Pandemics
Transportation
Problem, Solution, SitRep, or ?: 
Situation Report

Vaccine Unproven? No Problem in China, Where People Scramble for Shots

Tue, 2020-11-17 11:29 — mike kraft
Vaccine unproven? No problem in China, where people scramble for shots China has made its unproven candidates widely available to demonstrate their safety and effectiveness to a country that has long been skeptical of vaccines after a spate of quality scandals. Government officials and top pharmaceutical executives speak proudly of being inoculated. Sui-Lee Wee and Elsie Chen courant.com
Country / Region Tags: 
China
Global
General Topic Tags: 
COVID-19
Contagion
Disease
Government
Health
Pandemics
Policy
Science
Problem, Solution, SitRep, or ?: 
Situation Report

Pfizer to start pilot delivery program for its COVID-19 vaccine in four U.S. states

Tue, 2020-11-17 11:16 — mike kraft
Pfizer to start pilot delivery program for its COVID-19 vaccine in four U.S. states Pfizer Inc <PFE.N> has launched a pilot delivery program for its experimental COVID-19 vaccine in four U.S. states, as the U.S. drugmaker seeks to address distribution challenges facing its ultra-cold storage requirements. Reuters Staff U.S.
Country / Region Tags: 
Germany
Global
United States
General Topic Tags: 
COVID-19
Contagion
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Hospital-Acquired SARS-CoV-2 InfectionLessons for Public Health

Mon, 2020-11-16 20:23 — mike kraft
Hospital-Acquired SARS-CoV-2 Infection This Viewpoint reviews the rare incidence of nosocomial SARS-CoV-2 infection and discusses ways it can be minimized, including use of surgical masks, proper ventilation, physical distancing, eye protection, regular testing, and the availability of sick leave for health care workers. JAMA_current
Country / Region Tags: 
Canada
Global
United States
General Topic Tags: 
COVID-19
Data
Contagion
Disease
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Analysis

WHO tempers prospect of a coronavirus vaccine with warning of a long distribution fight to come

Mon, 2020-11-16 19:33 — mike kraft
WHO tempers prospect of a coronavirus vaccine with warning of a long fight to come Finding a coronavirus vaccine is like building a base camp on Mount Everest, not reaching the summit, the WHO says. Adam Taylor Washington Post
Country / Region Tags: 
Africa
Global
SouthEast Asia
United Nations
General Topic Tags: 
COVID-19
Contagion
Disease
Government
Health
Pandemics
Research
Science
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Pfizer vs Moderna vaccines: What we know, and what we don't

Mon, 2020-11-16 19:21 — mike kraft
Pfizer vs Moderna vaccines: What we know, and what we don't Two vaccine candidates using similar technology are winning the COVID-19 vaccine race in the U.S., and in the process validating the mRNA platform — which is yet untested on the market— as well as setting the path for vaccine makers to follow in order to block the virus. YahooNews
Country / Region Tags: 
Europe
Germany
Global
United States
General Topic Tags: 
COVID-19
Contagion
Disease
Health
Pandemics
Research
Science
Problem, Solution, SitRep, or ?: 
Analysis

But Landon and other experts say people should be cautious when using risk assessment tools and not rely too heavily on a single source, which could create a false sense of security as cases continue to surge

Mon, 2020-11-16 12:42 — mike kraft
Why experts urge caution in using covid risk and tracking tools As coronavirus cases surge ahead of Thanksgiving and the holiday season, relying on a single tool or data point could create a false sense of security, experts say. Allyson Chiu Washington Post
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Data
Communication
Contagion
Disease
Health
Pandemics
Problem, Solution, SitRep, or ?: 
Analysis

Bars and shops closed as Europe battles second wave of coronavirus

Mon, 2020-11-16 12:19 — mike kraft
Bars and shops closed as Europe battles second wave of coronavirus Strict measures – including curfews and states of emergencies – are in force once more across the continent as Covid cases surge Emma Graham-Harrison the Guardian
Country / Region Tags: 
Europe
France
Germany
Global
General Topic Tags: 
COVID-19
Data
Contagion
Disease
Government
Pandemics
Policy
Problem, Solution, SitRep, or ?: 
Situation Report

Canadian coronavirus cases grow and spread as once-effective unity frays

Mon, 2020-11-16 11:04 — mike kraft
Canadian coronavirus cases grow and spread as once-effective unity frays Cracks are emerging in the “Team Canada” approach; a spiraling resurgence is buffeting provinces once heralded as success stories. Amanda Coletta Washington Post
Country / Region Tags: 
Canada
Global
General Topic Tags: 
COVID-19
Data
Contagion
Disease
Government
Pandemics
Policy
Politics
Problem, Solution, SitRep, or ?: 
Situation Report

Pages

Subscribe to Global
howdy folks
Page loaded in 1.333 seconds.